Neoadjuvant Immunotherapy Yields OS Benefit in Glioblastoma

(MedPage Today) -- Small study finds " timing matters " for anti-PD-1 immunotherapy

Source: MedPage Today Hematology/Oncology - February 13, 2019 Category: Hematology Source Type: news